Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis

NCT01473797 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis of Lung

Interventions

DRUG: Cladribine

Sponsor

Assistance Publique - Hôpitaux de Paris